MiNK Therapeutics Inc. (INKT)
0.86
0.01 (1.18%)
At close: Jan 15, 2025, 3:59 PM
0.87
0.60%
After-hours Jan 15, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 3.37M | 19.64M | 38.89M | 2.69M | 299.04K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | -0.00 | 0.00 | n/a | -0.00 |
| Receivables | n/a | n/a | 23.00K | n/a | n/a |
| Inventory | n/a | n/a | 1.76K | 1.03M | 87.70K |
| Other Current Assets | 231.07K | 768.97K | 723.08K | 1.41M | 619.36K |
| Total Current Assets | 3.60M | 20.40M | 39.63M | 4.10M | 918.40K |
| Property-Plant & Equipment | 953.98K | 1.07M | 606.60K | 458.38K | 390.52K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 953.98K | 1.07M | 606.60K | 458.38K | 390.52K |
| Total Assets | 4.55M | 21.47M | 40.24M | 4.56M | 1.31M |
| Account Payables | 3.91M | 5.82M | 3.00M | 3.14M | 2.46M |
| Deferred Revenue | n/a | n/a | n/a | n/a | 191.01K |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 7.49M | 6.86M | 13.47M | 10.76M | 4.77M |
| Total Current Liabilities | 11.40M | 12.68M | 16.47M | 14.22M | 7.42M |
| Long-Term Debt | n/a | n/a | n/a | 43.82M | 26.79M |
| Other Long-Term Liabilities | 11.21M | 9.19M | n/a | 383.06K | 3.43M |
| Total Long-Term Liabilities | 11.21M | 9.19M | n/a | 44.21M | 30.22M |
| Total Liabilities | 22.61M | 21.87M | 16.47M | 58.43M | 37.64M |
| Total Debt | n/a | n/a | n/a | 43.82M | 26.79M |
| Common Stock | 346.00 | 339.00 | 335.00 | 242.00 | 241.00 |
| Retained Earnings | -133.40M | -110.94M | -82.95M | -52.74M | -36.50M |
| Comprehensive Income | -430.95K | -292.47K | -625.27K | -1.52M | -132.59K |
| Shareholders Equity | -18.06M | -401.30K | 23.78M | -53.87M | -36.33M |
| Total Investments | n/a | n/a | n/a | n/a | n/a |